Align Technology recently recorded a golden cross pattern, as its 50-day simple moving average rose above its 200-day average for the first time since early 2022. This technical development occurred after ALGN found support near its 100-day trendline, marking a 12% bounce from that level over the past six weeks. Traders often view this crossover as a bullish signal, suggesting growing momentum that could propel the stock higher if volume trends remain elevated.

Wall Street analysts project that Align Technology will report quarterly revenue growth of 3.9% year-over-year in its upcoming Q4 release, driven by continued demand for Clear Aligner treatments and an 8% increase in scanner unit shipments. Consensus expectations for adjusted earnings per share stand at a 22.5% rise versus the prior year, reflecting improved manufacturing efficiencies and higher utilization rates at its San Jose production facility. If realized, these figures would mark the fifth consecutive quarter of double-digit EPS expansion.

Despite robust top- and bottom-line estimates, ALGN enters earnings season without the full complement of traditional beat catalysts. While Clear Aligner volume gains and pricing discipline support revenue forecasts, potential headwinds include supply-chain delays for key optical components and intensifying competition in Europe. Analysts peg the probability of an earnings beat at 55%, noting that a surprise upside in accessories revenue or an acceleration in international service contracts could tip the scales in Align’s favor.